Trial intelligence / Profile preview

Vascular Function and Biomarkers in Healthy Volunteers and T2D Patients

NCT04744636Phase 1Completed

Sponsor
Servier
Start
Apr 2017
Primary completion
Sep 2018
Countries
1
01

Overview

Phase 1, open-label trial (4 arms), sponsored by Servier. Primary endpoint: Guanylate triphosphate cyclohydrolase investigations at Day 2. Started Apr 2017; status: completed.

Beyond the preview

Go deeper on NCT04744636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04744636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call